Skip to content

Latest podcast knowledge.

New episodes processed by Podwise, ready to search, skim and continue in the full app.

Just summarized

Read what each episode covers before you press play.

万物生长FM

头对头赢过K药这两年,康方生物怎么了?E.252

AI summary 康方生物及其核心药物依沃西单抗的临床表现与全球化进程,是当前创新药领域的核心议题。依沃西单抗通过双特异性抗体机制,在多项中国临床试验(如 HARMONi-2 和 HARMONi-6)中展现出优于传统 PD-1 抑制剂的疗效,成功改写了肺癌治疗标准。然而,其全球多中心临床试验面临人群差异、统计学门槛及执行一致性等多重挑战,导致市场预期出现显著波动。尽管与 Summit…

  • ASCO
  • 依沃西单抗
  • PD-1

01:03:13ChineseSummary · Transcript

AGI原野 | 技术创业现场

EP21. Manus的出海历险:一家公司的选择,如何成为一个时代的注脚

AI summary Manus 的发展历程折射出 AI 创业公司在复杂地缘政治与监管博弈中的生存困境。作为一家 AI Agent 产品公司,Manus 在获得硅谷风投 Benchmark 投资后,迅速遭遇美国 “反向 CFIUS” 审查,被迫将总部迁至新加坡以规避风险。随后,Meta 对其发起的收购引发了中国商务部关于技术出口的国家安全审查,最终导致交易撤销并由中资机构回购。这一系列跌宕起伏的资本运作与监管干预,不仅揭示了中美科技竞赛下 “科技回流” 的政策暗线,也为寻求全球化发展的创业者提供了关于政治敏感性与合规边界的深刻警示。Manus 的经历证明,在 AI…

  • Manus
  • 蝴蝶效应
  • DeepSeek

45 minChineseSummary · Transcript

Beyond The Prompt - How to use AI in your company

Whatever You Might Think About AI, You Must Feel Awe: Pulitzer Finalist Robert Wright on “The God Test”

AI summary Artificial intelligence is evolving into a potential "global brain," a superintelligence that may eventually possess governing authority. This technological shift demands a new, cohesive international framework to manage existential risks, such as the development of bioweapons…

  • The God Test
  • Awe Spectrum
  • Global Brain

00:51:31EnglishSummary · Transcript

Equity

How backlash and red tape continue to slow data centers post-Blue Wave

AI summary Data center development faces a significant disconnect between projected capacity and actual infrastructure delivery, driven by speculative "large load" queues that often overestimate realistic build-outs by an order of magnitude. While hyperscalers and AI firms scramble for…

  • Anthropic
  • Hyperscaler
  • ERCOT

33 minEnglishSummary · Transcript

万物生长FM

艾伯维,何以成为免疫之王|跨国药企简史E.257

AI summary 艾伯维通过精密的专利丛林构建、诉讼和解及 PBM 反点机制,成功化解了 “药王” 修美乐专利到期带来的巨大冲击。在核心产品面临专利悬崖时,公司利用深厚的现金流优势,通过并购利生奇珠单抗和乌帕替尼等临床后期资产,迅速完成了第二增长曲线的接棒。这种以现金流为驱动的商业模式,通过优化给药方式和拓展适应症,将新药迅速推向百亿销售规模。艾伯维的成功不仅在于分子的选择,更在于其强大的组织执行力,即在旧产品盈利期内主动完成处方转移,并利用医美与神经科学业务的稳定性对冲免疫领域的周期性风险,展现了跨国药企在专利生命周期管理中的极致策略。

  • 艾伯维
  • 修美乐
  • 生物类似药

01:03:35ChineseSummary · Transcript

More new episodes

  1. Summary
  2. Summary40 min
  3. Summary3 min
  4. Summary00:41:05
  5. Summary00:41:55
  6. Summary1 h 15 min
  7. Summary33:47
  8. Summary00:42:09
  9. Summary27:35
  10. Summary27 min
  11. 66: Be a Sales Diagnostician with Steve Richard

    Management Blueprint | Steve Preda

    Summary34:22
  12. Summary00:51:07
  13. AI for Conversation Intelligence

    The AI for Sales Podcast

    Summary00:40:22
  14. Summary00:27:32
  15. Ep 55 | 未来12个月,科技资产信号

    非共识的20分钟

    Summary11 min
  16. Summary00:31:45
  17. Summary01:04:19
  18. Summary47 min
  19. Summary00:50:51
  20. Forward Deployed Engineer: What It Is and How to Become One

    AI News & Strategy Daily with Nate B. Jones

    Summary26:28
  21. Summary00:45:33
  22. Summary1 h 9 min
  23. Summary00:51:37
  24. 第234期 AI 界卧龙凤雏

    后互联网时代的乱弹

    Summary1 h 36 min
  25. Summary15 min
Podwise

Summaries for every new episode.

Follow your shows in Podwise and read each new episode before you decide to listen.